Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07217093 · ClinicalTrials.gov registry record

Teleconsultation Approach to CTD-ILD Care Delivery in Rural UnderServed CommuniTies (TRUST Initiative)

A clinical trial, sponsored by St. Lawrence Health System.

Not yet
Registry status
10
Enrollment target

NCT07217093 is a clinical trial that has not yet begun recruiting, run by St. Lawrence Health System. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07217093 has not yet begun recruiting, sponsored by St. Lawrence Health System.

NOT YET RECRUITING
Registry status
10 participants
Enrollment target

Study Summary

Connective tissue disease-associated interstitial lung disease (CTD-ILD) is a rare and complex condition that affects some individuals with autoimmune disorders such as rheumatoid arthritis (RA). It can lead to inflammation and progressive scarring of the lungs, significantly affecting quality of life and overall prognosis.1 Current clinical guidelines recommend that patients with CTD-ILD receive care at specialized academic medical centers with multi-disciplinary teams experienced in managing interstitial lung disease (ILD).2 These centers, however, are often located in urban areas, making access particularly challenging for patients living in rural and underserved regions. In rural, medically underserved areas, the nearest ILD centers can be three or more hours away, posing substantial barriers to timely, consistent, and expert care. These logistical constraints make it difficult for patients residing in rural areas to access the high-quality, specialized care required to manage CTD-ILD effectively. The Teleconsultation Approach to CTD-ILD Care Delivery in Rural Underserved Communities (TRUST Initiative) it looking to address this gap in access to specialized care. The TRUST Initiative aims to evaluate whether integrating teleconsultation into a personalized, multidisciplinary care model, through regular, structured teleconsultation visits, can enhance the quality and coordination of treatment for patients and potentially other rural underserved patient populations. This model utilizes a regional rheumatologist, a regional pulmonologist and, an interstitial lung disease (ILD) specialist at the Mayo Clinic in Rochester, Minnesota. This model seeks to overcome the geographic and logistical challenges that prevent patients from accessing specialty care. It also offers a replicable care model for managing other complex chronic diseases in underserved rural communities by leveraging collaborative care, virtual health technology, and structured communication workflows

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2025-11
Est. Completion 2026-12

Sponsor

St. Lawrence Health System

2 total trials

What the Registry Record Tells You About NCT07217093

The ClinicalTrials.gov registry entry for NCT07217093 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Lawrence Health System, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT07217093 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07217093 about?

NCT07217093 is a clinical study titled "Teleconsultation Approach to CTD-ILD Care Delivery in Rural UnderServed CommuniTies (TRUST Initiative)". Connective tissue disease-associated interstitial lung disease (CTD-ILD) is a rare and complex condition that affects some individuals with autoimmune disorders such as rheumatoid arthritis (RA). It can lead to inflammation and progressive scarring of the lungs, significantly affecting quality of li...

What is the current status of trial NCT07217093?

This trial is currently not yet recruiting. The enrollment target is 10 participants. The study started on 2025-11. Estimated completion is 2026-12.

Who is sponsoring clinical trial NCT07217093?

This trial is sponsored by St. Lawrence Health System, which has 2 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.